CellaVision s analyzer important tool in innovative telediagnostic project in Germany

The University Hospital in Berlin claims prize for quality assurance
of blood analyses

Dr Andreas Weimann of Charité, medical faculty at the Berlin
University Hospitals, is this year's winner of the prestigious German
healthcare prize, the Richard Merten Preis. He is awarded the prize
for his work on improving and economizing the communication of
medical results between three laboratory units of the Berlin
University Hospitals. Using CellaVision products, the project has
resulted in an improved workflow and more standardized test results."Without CellaVision's excellent products I would never have been
able to carry out this project and promote and advance it," says Dr
Andreas Weimann. "Using telehaematology I have been able to
strengthen the cooperation within and between laboratories and make
the laboratory workflow a lot more efficient."

When the three laboratory units of the three University Hospitals in
Berlin merged, CellaVision's products for routine analysis of blood
and quality assurance became an important factor for the success of
Dr Andreas Weimann's project. The hospital invested in a modern IT
solution with products from CellaVision and Sysmex in order to lower
costs while also strengthening online communication between
information systems and instruments at the laboratories. Regardless
of physical location, it is possible for the laboratory personnel to
assess and diagnose samples online."We congratulate Dr Weimann on receiving this prize, and are of
course very pleased that our products have helped him in creating
improved, cost-efficient communication between the laboratory units
in Berlin," says Yvonne Mårtensson, CEO of CellaVision.

The Richard Merten Preis is a distinction that rewards prominent
medical projects that aim to quality assure and develop German
healthcare using modern IT-solutions. The prize of € 10 000 is
rewarded annually by the Richard-Merten-Preis foundation. For more
information, visit www.richard-merten-preis.de

The prize will be handed over today, Wednesday the October 31, at a
ceremony in Frankfurt.

Read the Richard Merten Preis committee's abstract of the project by
pressing the link below.

For more information, please contact:
Yvonne Mårtensson, CEO, CellaVision AB
Phone: +46 286 44 00. E-mail: yvonne.martensson@cellavision.com

About Charité
Charité - Universitätsmedizin Berlin is Europe's largest university
hospital with 7 500 students, 15 000 employees, and over 1 million
patients. The hospital offers both highly specialised and basic
healthcare as well as research and education. For more information,
visit www.charite.de

About CellaVision
CellaVision AB develops, markets, and sells the market leading image
analysis based systems for routine analysis of blood. The company has
a core competence in development of software and hardware for
automatic image analysis of cells and cell changes for applications
in health and medical care. The company develops and markets systems
for automatic differentials of white blood cells and red morphology,
and software for education and quality assurance of differentials.
The company's associates have expertise in advanced imaging analysis,
artificial intelligence, and automated microscopy.

The company headquarters are in Lund, Sweden. The company also has
subsidiaries Jupiter, Fl, USA, and Toronto, ON, Canada. For more
information, visit www.cellavision.com.

CellaVision's share is listed on First North at the OMX Stockholm
Stock Exchange. The company's Certified Advisor is Remium AB.